Results 211 to 220 of about 110,182 (337)

Salivary gland lymphoplasmacytoid lymphoma with nodular cutaneous amyloid deposition and lambda chain paraproteinaemia [PDF]

, 1996
A. Badell, Octavio Servitje, Jordi Graells, N. Curcó, J. Notario, Jordi Peyrı́   +5 more
openalex   +1 more source

Enigmatic Presentation of Primary Cutaneous Lymphoma in a Boy. [PDF]

Plast Reconstr Surg Glob Open
Farhan A, Fakhro A, Burshaid D.
europepmc   +1 more source

Mycosis Fungoides with Dermal Mucin Deposition: An Unusual Variant of the Most Challenging Primary Cutaneous Lymphoma. [PDF]

Case Rep Dermatol, 2021
Filosa A, Simonetti S, Zanelli M, Zizzo M, Stingeni L, Martino G, Collina G, Ascani S.   +7 more
europepmc   +1 more source

Retroviruses and Cutaneous T-Cell Lymphoma

, 1994
Stuart R. Lessin, Benjamin R. Vowels, Alain H. Rook   +2 more
openalex   +1 more source

Dysregulated Synthesis of Intracellular Type 1 and Type 2 Cytokines by T Cells of Patients with Cutaneous T-Cell Lymphoma [PDF]

, 1999
Bang‐Ning Lee, Madeleine Duvic, Chih-Kwang Tang, Carlos Bueso-Ramos, Zeev Estrov, James M. Reuben   +5 more
openalex   +1 more source

Low‐dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome: Results From the Prospective S‐MISR Study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Erythrodermic mycosis fungoides (eMF) and Sézary syndrome (SS) often show delayed and non‐durable clinical responses to systemic therapies. Patients and Methods A total of 35 patients with eMF or SS were treated with total skin electron beam therapy (TSEBT).
Khaled Elsayad, Christian Kandler, Jan Jakob Siats, Niklas Pepper, Moritz Fabian Danzer, Gabor Dobos, Elisabeth Livingstone, Susanne Melchers, Johannes Kleemann, Julia Hyun, Claudia Pföhler, Peter von den Driesch, Jan P. Nicolay, Rudolf Stadler, Hans Theodor Eich   +14 more
wiley   +1 more source

Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool. [PDF]

Front Oncol
Ivert LU, Winther AH, Jonsson P, Brauner H.   +3 more
europepmc   +1 more source

Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy. [PDF]

J Allergy Clin Immunol
Cabrera-Perez JS, Carey VJ, Odejide OO, Singh S, Kupper TS, Pillai SS, Weiss ST, Akenroye A.   +7 more
europepmc   +1 more source

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.

Blood, 2022
Olsen EA, Whittaker S, Willemze R, Pinter-Brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J, Kim YH, Wood GS, Duvic M, Ai W, Girardi M, Gru A, Guenova E, Hodak E, Hoppe R, Kempf W, Kim E, Lechowicz MJ, Ortiz-Romero P, Papadavid E, Quaglino P, Pittelkow M, Prince HM, Sanches JA, Sugaya M, Vermeer M, Zain J, Knobler R, Stadler R, Bagot M, Scarisbrick J.   +34 more
europepmc   +1 more source

A retrospective review of cutaneous lymphoma in Botswana. [PDF]

Int J Dermatol, 2020
Rodriguez O, Sowash M, Mosojane KI, Ralefala T, Grover S, Haun P, Kovarik C, Williams VL.   +7 more
europepmc   +1 more source